Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07728409) titled 'Silver Nanoparticle vs Chlorhexidine Mouthwashes for Reducing Streptococcus Mutans and Improving Salivary pH in Children' on July 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Assiut University

Condition: Dental Caries Prevention

Intervention: Drug: Silver nanoparticle mouthwash (10 ppm)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: August 5, 2026

Target Sample Size: 96

To know more, visit...